Alpha Cognition Inc (NASDAQ: ACOG) is a Healthcare company (Biotechnology) with a market capitalization of $123M. The Maz Rating grades it against the other companies in its sector.
Alpha Cognition Inc's current Maz Rating and its five factor grades are for members: log in to see them.
At $7.92, Alpha Cognition Inc trades at 6.1x sales and 3.5x book value. Over the last twelve months it generated about $20M of revenue and a net loss of $21M. It runs a gross margin of 93.1%, an operating margin of -149.6% and a net margin of -147.3%. It shows return on equity of -53.5%, return on invested capital of -54.0% and a free cash flow yield of -25.2%. On the balance sheet: a debt-to-equity ratio of 0.00 and a current ratio of 7.13. Over the past 52 weeks the share price ranged from $4.50 to $10.14, with a beta of 2.33.
Alpha Cognition Inc does not currently pay a dividend.
1 Wall Street analyst rating covers the stock: 1 Buy, for a Buy consensus. This is the sell side's view, separate from the Maz Rating.
Figures are trailing twelve months unless stated. The Maz Rating and Maz Dividend Score rank a company against its own sector; they are not price targets or recommendations.